Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel protein therapeutics for cancer and rare diseases, today announced
its participation at the 21st Annual Future Leaders in the
Biotech Industry Conference to be held on March 28, 2014 at the
Millennium Broadway Hotel & Conference Center in New York City.
A live audio webcast of the presentation will be available on the
"Events and Presentations" page in the Investors & Media section on the
Company's website (http://investor.acceleronpharma.com/events.cfm).
A replay of the webcast will be available from Acceleron's website for
thirty days after the conference.
Acceleron is a clinical stage biopharmaceutical company focused on the
discovery, development and commercialization of novel protein
therapeutics for cancer and rare diseases. The company is a leader in
understanding the biology of the Transforming Growth Factor-Beta (TGF-ß)
protein superfamily, a large and diverse group of molecules that are key
regulators in the growth and repair of tissues throughout the human
body, and in targeting these pathways to develop important new
medicines. Acceleron has built a highly productive R&D platform that has
generated innovative clinical and preclinical protein therapeutic
candidates with novel mechanisms of action. These protein therapeutic
candidates have the potential to significantly improve clinical outcomes
for patients with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
[ Back To NFVZone's Homepage ]